-
Immediate Postoperative Minimal Residual Disease Detection with MAESTRO Predicts Recurrence and Survival in Head and Neck Cancer Patients Treated with Surgery
Study
phs003981
-
Dynamic Evolution of Fibroblasts Revealed by Single Cell RNA Sequencing of Human Pancreatic Cancer
Study
phs003751
-
Sequence data to study genomic CNVs that drive apoptotic resistance and relapses on immune checkpoint inhibitors
Study
EGAS50000001055
-
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high risk lineage ambiguous leukemia
Study
EGAS50000001255
-
Sequencing of pancreatic cancer primary tumors and metastases
Study
EGAS00001002186
-
Investigation_of_mutational_signatures_associated_with_DNMT3A_deficiency_
Study
EGAS00001002329
-
CRLF2_sequencing_project_
Study
EGAS00001000080
-
H3K27ac ChIP-seq in TMPRSS2:ERG positive and negative prostate cancer tissue samples
Study
EGAS00001002496
-
Autozygosity_pilot___Pakistani_from_Birmingham
Study
EGAS00001000511
-
CRLF2_sequencing_project_Exomes
Study
EGAS00001000081
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004008
-
Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer
Study
EGAS00001003367
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
PDX_models_from_Latin_America_WES_
Study
EGAS00001005663
-
Single-cell and spatial transcriptomic profiling of hormone-naïve localised prostate cancer
Study
EGAS00001008332
-
Centers for Common Disease Genomics (CCDG) - Whole Genome Sequencing in Type 1 Diabetes (T1DGC)
Study
phs001222
-
DNA-Sequencing of Baseline Plasma From the Phase III Alliance A031201 Trial
Study
phs003325
-
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to the Antibody Drug Conjugate Sacituzumab Govitecan
Study
phs002555
-
Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies
Study
JGAS000052
-
Therapeutic Resistance to PI3K-alpha Inhibitors
Study
EGAS00001000991
-
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
Study
phs002334
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. RNA-Seq
Study
EGAS50000000567
-
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumour DNA
Study
EGAS50000000873
-
Identification and targeting of extremely high-risk gamma delta T-ALL in children
Study
EGAS50000000018